Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis
- PMID: 20595689
- PMCID: PMC2974380
- DOI: 10.2215/CJN.01270210
Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis
Abstract
Background and objectives: Antibiotic locks in catheter-dependent chronic hemodialysis patients reduce the rate of catheter-related blood stream infections (CRIs), but there are no data regarding the long-term consequences of this practice.
Design, setting, participants, & measurements: Over a 4-year period, from October 1, 2002, to September 30, 2006, we initiated a gentamicin and heparin lock (GHL) protocol in 1410 chronic hemodialysis patients receiving dialysis through a tunneled catheter in eight outpatient units.
Results: Within the first year of the GHL protocol, our CRI rate decreased from 17 to 0.83 events per 1000 catheter-days. Beginning 6 months after initiation of the GHL protocol, febrile episodes occurred in 13 patients with coagulase-negative Staphylococcus bacteremia resistant to gentamicin. Over the 4 years of GHL use, an additional 10 patients developed 11 episodes of gentamicin-resistant CRI (including 7 with Enterococcus faecalis), in which there were 4 deaths, 2 cases of septic shock requiring intensive care unit admission, and 4 cases of endocarditis. Because of these events, the GHL protocol was discontinued at the end of 2006.
Conclusions: Although the use of GHL effectively lowered the CRI rate in our dialysis population, gentamicin-resistant CRIs emerged within 6 months. Gentamicin-resistant infections are a serious complication of the long-term use of GHLs. Alternative nonantibiotic catheter locks may be preferable to decrease the incidence of CRIs without inducing resistant pathogens.
Figures
References
-
- Centers for Medicare and Medicaid Services: 2004 Annual report: End-stage renal disease clinical performance measures project. Am J Kidney Dis 46: 1–100, 2005
-
- Vascular Access Working Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S248–S273, 2006 - PubMed
-
- Allon M: Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 44: 779–791, 2004 - PubMed
-
- Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ: Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study. J Am Soc Nephrol 14: 1863–1870, 2003 - PubMed
-
- Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled haemodialysis catheter-related infections using catheter-restricted gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 12: 2133–2139, 2002 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
